Cure Brain Cancer was founded as Cure For Life Foundation.

First major fundraising event held, the Gala Ball.

First research grant delivered to Dr. (now Professor) David Walker of QIMR Berghofer to develop a new model for malignant brain tumours; a breakthrough for translational research.

Funding commences for Children’s Cancer Institute of Australia (CCIA) and UNSW investigating mechanisms of initiation and prevention of brain tumours.

‘Walk4Life’ fundraising campaign launched.

Foundation commences funding of Visiting Fellowship Programme at Lowy Cancer Research Centre, UNSW, bringing international experts in the field to work with Australian teams.

The Brain Cancer Discovery Collaborative (BCDC), launches with a $1,000,000 of funding courtesy of the Foundation.

Cure for Life Foundation rebrands to become Cure Brain Cancer Foundation and awards over $2 million in Innovation and Clinical grants

Together with our partners, we announce funding for Zero Childhood Cancer, a personalised medicine and clinical trial program for children.

Cure Brain Cancer Foundation is named Charity of the Year at the Third Sector Awards.

Launch of our Early Career Fellowship program, awarding two high impact projects with a total investment of $690,000.

Successful campaigning from Cure Brain Cancer Foundation ensures the drug Avastin is listed on the Pharmaceutical Benefits Scheme for recurrent glioblastoma patients, saving families up to $30,000.

Launch of the Breast and Brain Collaborative with the National Breast Cancer Foundation, jointly funded high impact translational research that spans both primary brain cancer and breast cancers.

CBCF invests over $800,000 in Innovation Grants to fund several promising research projects, including Professor Misty Jenkins’ groundbreaking work in CAR-T cells, a type of immunotherapy—research that continues to progress today.

Launch of the National Advocacy Service, on which we proudly partner with Peace of Mind Foundation.

The Foundation awards its first-ever Mid-Career Fellowship to Dr. Hsiao Voon of Monash University and its first Clinical Accelerator Grant to Professor Terrence Johns at the Telethon Kids Cancer Centre.

A milestone year for the Foundation with the launch of the revolutionary, first of its kind clinical trial GBM AGILE.

GBM AGILE expands to six sites, actively recruiting patients in QLD, NSW and VIC.

Cure Brain Cancer Foundation marks 25 years of advancing brain cancer research, support and awareness.